| |
Maine Medical Center and Maine State Cancer Registry Will Soon
Complete IMPAC PathConnect™ Beta Installation
Electronic transfer of synoptic data between pathology and
cancer registry systems will support RPP2 goals
In
an ongoing effort to improve the quality and efficiency of data acquisition into IMPAC Cancer Registry, IMPAC has nearly completed
installation of the PathConnect
interface between PowerPath,
IMPAC’s anatomic pathology management solution and MRS, one of
IMPAC’s leading cancer registry products. PathConnect leverages
IMPAC’s expertise in both these areas and gives us an
opportunity to participate in the development of a new interface
standard.
The new pathology-to-registry interface automates the process of
acquiring pathology data for cancer registry.
Back to Top |
|
|
|
For more than a year, the collaboration between IMPAC, Maine Medical Center, and
Maine State Cancer Registry, and Dahl Chase Pathology Laboratories
under the direction of the Centers for Disease Control/National
Program of Cancer Registries, will soon enter clinical data collection
and testing of messages that conform to HL7, DICOM, and CAP Protocol
standards. The expedited transfers of anatomic pathology’s more
detailed synoptic reports ultimately benefit cancer registries'
ability to analyze cancer's origins and the efficacy of treatments.
IMPAC will continue to update you about this exciting news at
www.impac.com.
|
|
